Exploring FGFR2b in Gastric and GEJ Cancer [Podcast] Ep. 213

Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!

Fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) is an emerging biomarker present in about 38% of patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma. In this episode, CANCER BUZZ speaks with Nataliya Uboha, MD, PhD, a medical oncologist at University of Wisconsin Health, about current recommendations for biomarker testing in this population, emerging biomarkers such as FGFR2b, and how multidisciplinary collaboration can ensure patients receive timely biomarker testing. CANCER BUZZ also interviews Wendi Waugh, BS, RT(R)(T), CMD, ODS, FACCC, administrative director of cancer services and ambulatory infusion at Southern Ohio Medical Center, about care coordination strategies and lessons learned from her team’s experience administering biomarker testing. Finally, Kristina A. Matkowskyj, MD, PhD, pathologist at Mayo Clinic, explains the vital role of pathologists in identifying biomarkers and strategies for success in biopsies.

“We have to work closely with our pathology colleagues to make sure that all of the tests are done quickly and so that they are readily available by the time the patient is seen in clinic.” - Nataliya Uboha, MD, PhD

“Tracking, knowing what and when new things come out, being able to mine your data to find those things, I think is going to be uber critical.” - Wendi Waugh, BS, RT(R)(T), CMD, ODS, FACCC

“I believe that the precision medicine testing that we’re doing today... is going to change the face of cancer care.” - Wendi Waugh, BS, RT(R)(T), CMD, ODS, FACCC

“As a pathologist, if I was able to stress one thing, it would be to collect as many biopsies as is safely possible for that particular patient.” - Kristina A. Matkowskyj, MD, PhD


/images/podcast/uboha---circle.png

Nataliya Uboha, MD, PhD
Medical Oncology
University of Wisconsin Health
Madison, WI


/images/podcast/waugh---circle.png

Wendi Waugh, BS, RT(R)(T), CMD, ODS, FACCC
Administrative Director of Cancer Services & Ambulatory Infusion
Southern Ohio Medical Center
Portsmouth, OH


/images/podcast/matkowskyj---circle.png


Kristina A. Matkowskyj, MD, PhD
Pathologist
Mayo Clinic
Rochester, MN



The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.

Upcoming Events

Virtual Oncology Reimbursement Meeting (ORM) | Winter 2026

Virtual Oncology Reimbursement Meeting (ORM) | Winter 2026

Virtual December 9, 2026 at 11:00 AM EST
2027 ACCC Leadership Summit

2027 ACCC Leadership Summit

In Person April 22, 2027 at 6:00 PM EDTWillard InterContinental Hotel, 1401 Pennsylvania Avenue Northwest, Washington, DC, USAWashington